These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7889266

  • 1. Antianginal effects of FK409, a new spontaneous NO releaser.
    Kita Y, Ozaki R, Sakai S, Sugimoto T, Hirasawa Y, Ohtsuka M, Senoh H, Yoshida K, Maeda K.
    Br J Pharmacol; 1994 Dec; 113(4):1137-40. PubMed ID: 7889266
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antiplatelet activities of FK409, a new spontaneous NO releaser.
    Kita Y, Hirasawa Y, Yoshida K, Maeda K.
    Br J Pharmacol; 1994 Oct; 113(2):385-8. PubMed ID: 7834188
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Close correlation of the cardioprotective effect of FK409, a spontaneous NO releaser, with an increase in plasma cyclic GMP level.
    Kita Y, Sugimoto T, Hirasawa Y, Yoshida K, Maeda K.
    Br J Pharmacol; 1994 Sep; 113(1):5-6. PubMed ID: 7812632
    [Abstract] [Full Text] [Related]

  • 6. Comparison of hemodynamic effects of nitric oxide (NO) donors with different NO-releasing properties in rats.
    Kita Y, Hirasawa Y, Kato Y, Ohkubo K, Ohno M, Nishino S, Kato M, Fukuyama S.
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):223-8. PubMed ID: 9269950
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409.
    Kita Y, Hirasawa Y, Maeda K, Nishio M, Yoshida K.
    Eur J Pharmacol; 1994 May 12; 257(1-2):123-30. PubMed ID: 8082692
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Protective effect of FK409, a spontaneous nitric oxide releaser, on ischemic acute renal failure in rats.
    Matsumura Y, Nishiura M, Deguchi S, Hashimoto N, Ogawa T, Seo R.
    J Pharmacol Exp Ther; 1998 Dec 12; 287(3):1084-91. PubMed ID: 9864296
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic mechanisms of the antianginal action of a novel vasodilator FK409 in dynamic exercise-induced angina.
    Yokota M, Matsunami T, Kodama Y, Sobue T, Nishinaka Y, Iwase M, Miyahara T, Koide M, Saito H, Shibata S.
    J Cardiovasc Pharmacol; 1993 Mar 12; 21(3):412-22. PubMed ID: 7681502
    [Abstract] [Full Text] [Related]

  • 15. Structure-activity relationships of spontaneous nitric oxide releasers, FK409 and its derivatives.
    Fukuyama S, Hirasawa Y, Kato Y, Nishio M, Ohno M, Nishino S, Maeda K, Kato M, Kita Y.
    J Pharmacol Exp Ther; 1997 Jul 12; 282(1):236-42. PubMed ID: 9223559
    [Abstract] [Full Text] [Related]

  • 16. Renal hemodynamic and excretory responses in anesthetized rats to FK409, a novel nitric oxide donor.
    Urabe K, Matsumura Y, Nishiura M, Maeda K, Morimoto S.
    Eur J Pharmacol; 1997 Feb 26; 321(2):195-200. PubMed ID: 9063688
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.